These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 346041)

  • 1. Observations on the in vivo reaction of antinuclear antibodies with epidermal cells.
    Izuno GT
    Br J Dermatol; 1978 Apr; 98(4):391-8. PubMed ID: 346041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P; Peltier AP; Allegre P; Civatte J
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo epidermal nuclear reactions: a selective process.
    Koelle MS; Kumar V; Beutner EH; Chorzelski TP
    Br J Dermatol; 1991 Jul; 125(1):48-52. PubMed ID: 1873202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The speckled epidermal nuclear immunofluorescence of mixed connective tissue disease seems to develop as an in vitro phenomenon.
    Iwatsuki K; Tagami H; Imaizumi S; Ginoza M; Yamada M
    Br J Dermatol; 1982 Dec; 107(6):653-7. PubMed ID: 6756463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The speckled immunofluorescence of epidermal nuclei as an in vivo phenomenon.
    Parodi A; Nunzi E; Rebora A
    Br J Dermatol; 1985 May; 112(5):555-8. PubMed ID: 3890917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speckled (particulate) epidermal nuclear IgG deposition in normal skin. Correlation of clinical features and laboratory findings in 46 patients with a subset of connective tissue disease characterized by antibody to extractable nuclear antigen.
    Prystowsky SD; Tuffanelli DL
    Arch Dermatol; 1978 May; 114(5):705-10. PubMed ID: 348115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
    Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
    J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidermal nuclear fluorescence of normal skin in connective tissue diseases].
    Wollina U; Koch HJ; Knopf B
    Dermatol Monatsschr; 1984; 170(11):699-702. PubMed ID: 6394393
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms underlying the development of speckled epidermal nuclear immunofluorescence in patients with high titer antibodies to RNP (author's transl)].
    Iwatsuki K; Tagami H; Imaizumi S; Ginosa M; Yamada M
    Nihon Hifuka Gakkai Zasshi; 1982 Mar; 92(4):515-8. PubMed ID: 7050472
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
    Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antinuclear antibodies of the skin: A rare phenomenon on direct immunofluorescence.
    Chhabra S; Arora SK; Minz RW; Dogra S
    Dermatol Online J; 2013 Apr; 19(4):15. PubMed ID: 24021374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Torzecka D; Waszczykowska E
    Przegl Dermatol; 1990; 77(5):332-5. PubMed ID: 2125351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence.
    Burrows NP; Bhogal BS; Russell Jones R; Black MM
    J Cutan Pathol; 1993 Apr; 20(2):159-62. PubMed ID: 8320361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
    Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
    Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal nuclear immunofluorescence: serological correlations supporting an in vivo reaction.
    Chen ZY; Dobson RL; Ainsworth SK; Silver RM; Maricq HR
    Br J Dermatol; 1985 Jan; 112(1):15-22. PubMed ID: 3882123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro complement activation by antinuclear antibodies in the epidermis from patients with systemic sclerosis.
    Reimer G; Liebel G; Hornstein OP
    Br J Dermatol; 1984 Aug; 111(2):169-74. PubMed ID: 6380559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fixation in vivo of antinuclear antibodies].
    Guillet G; Fizet D; Claudy A; Thivolet J
    Nouv Presse Med; 1979 Mar; 8(11):869. PubMed ID: 377217
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.
    Reimer G; Huschka U; Keller J; Kammerer R; Hornstein OP
    Br J Dermatol; 1983 Jul; 109(1):27-36. PubMed ID: 6344904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nucleolar, homogeneous and peripheral fluorescence of epidermal nuclei in direct immunofluorescence: 4 cases (author's transl)].
    Morel P; Allègre P; Civatte J
    Ann Dermatol Venereol; 1979 Apr; 106(4):361-4. PubMed ID: 384881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.